Patent Open Access

An Antiviral Formulation with RNA Dependent RNA Polymerase & DNA Gyrase Suppressive Properties for the Treatment of Emerging Covid-19 Subvariants

Alkoclar, Erdal Can; Yesil, Metehan


JSON-LD (schema.org) Export

{
  "inLanguage": {
    "alternateName": "eng", 
    "@type": "Language", 
    "name": "English"
  }, 
  "description": "<p>A bioceutical formulation consisting of RNA Polymerase inhibiting and immunomodulatory features- exhibiting Glucopyranoside Analouges for the Adjunctive Treatment of Emerging Covid-19 Subvariants.</p>\n\n<p>&nbsp;</p>\n\n<p>Inventors: Erdal Can Alkoclar &amp; Metehan Yesil</p>", 
  "creator": [
    {
      "affiliation": "Mas Pharmaceuticals", 
      "@type": "Person", 
      "name": "Alkoclar, Erdal Can"
    }, 
    {
      "@type": "Person", 
      "name": "Yesil, Metehan"
    }
  ], 
  "url": "https://sciencerepository.dk/record/24", 
  "datePublished": "2022-07-08", 
  "version": "1.0", 
  "keywords": [
    "Omicron covid-19"
  ], 
  "@context": "https://schema.org/", 
  "identifier": "https://doi.org/10.82163/sciencerepository.24", 
  "@id": "https://doi.org/10.82163/sciencerepository.24", 
  "@type": "CreativeWork", 
  "name": "An Antiviral Formulation with RNA Dependent RNA Polymerase & DNA Gyrase Suppressive Properties for the Treatment of Emerging Covid-19 Subvariants"
}
0
0
views
downloads
All versions This version
Views 00
Downloads 00
Data volume 0 Bytes0 Bytes
Unique views 00
Unique downloads 00

Share

Cite as